ArticlePloS one2025
Hepatitis B (HBsAg) prevalence among obstetric patients in Caluquembe, Angola, 2023-2024.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesNewborns who contract hepatitis B virus (HBV) infections at birth often develop chronic infections that can cause cirrhosis, liver cancer, and death in middle adulthood. Birth doses of hepatitis B vaccine can be lifesaving for babies born to mothers with hepatitis B infections. We aimed to measure hepatitis B prevalence among maternity patients in Huíla, a rural province in southwestern Angola.
methodsWe conducted a prospective case series study among 317 peripartum women at the Hospital Evangélico de Caluquembe from November 2023 to February 2024. Each participant received a point-of-care hepatitis B surface antigen (HBsAg) test and was asked about HBV and vaccine knowledge. We also conducted qualitative interviews about HBV prevention with 26 healthcare workers.
resultsThe HBsAg prevalence was 4.7%. None of the women who tested positive was previously aware of her status. Only about one-third of the women expressed familiarity with hepatitis B or HBV vaccines, and almost none reported that their older children had received HBV vaccines. Maternal health workers proposed hosting community meetings to provide education about HBV and birth-dose vaccination.
conclusionsOnly about half of Angolan babies are born at healthcare facilities, but more than 80% of women attend at least one antenatal care visit. Improved access to and uptake of hepatitis B screening at antenatal checkups is essential for ensuring that babies born to women with chronic hepatitis B infections are able to receive birth dose hepatitis B vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.